Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Beta Bionics, Inc. (BBNX) Institutional Ownership & Insider Trading

134 institutions reported holding Beta Bionics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 55 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BBNXBeta Bionics, Inc.Follow BBNX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
862.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
27 Oct, in 3 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

134 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.6%.

Increased+52New+25Decreased-33Closed-21

Largest moves, shares (millions)

Divisadero Street Capital…+1.1MTri Locum Partners+0.5MGoldman Sachs Group+0.4MVestal Point Capital-0.6MRtw Investments-0.5MY-Intercept (Hong Kong)-0.4M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Mar 25+3.7Jun 25+3.4Sep 25-1.5Dec 25+2.2Mar 26+1.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2613448+3.6%52253321
Mar 2612949+5.0%45194443
Dec 2515647-3.2%54423113
Sep 2512549+7.5%55242116
Jun 2511445+8.9%34262410
Mar 2510342—————

Beta Bionics, Inc. — questions

Who owns Beta Bionics, Inc. stock?
134 institutions reported Beta Bionics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: EVENTIDE ASSET MANAGEMENT, LLC (13.9%), Soleus Capital Management, L.P. (9.8%), MORGAN STANLEY (9.5%).
Are Beta Bionics, Inc. insiders buying or selling?
55 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.